Skip to main content
. 2014 Nov 20;2014:497178. doi: 10.1155/2014/497178

Figure 2.

Figure 2

A patient with AMD previously treated with 4 intravitreal ranibizumab injections shows persistent subretinal retinal fluid on OCT (a). Following one intravitreal aflibercept injection (b) there was marked reduction of subretinal fluid and reduced CRT, 7.61 to 6.88 mm3 and 442 to 223 μm, respectively.